Participant Motivators and Expectations in the MEL-SELF Randomized Clinical Trial of Patient-Led Surveillance for Recurrent Melanoma: Content Analysis of Survey Responses

Participant Motivators and Expectations in the MEL-SELF Clinical Trial

Background

There is limited information about why patients join dermatology clinical trials, especially for melanoma. Understanding what motivates participants is crucial for improving trial methods.

Objective

This study aimed to discover what motivates patients to participate in the MEL-SELF trial, which focuses on patient-led monitoring for melanoma.

Methods

The MEL-SELF trial is recruiting patients who have had localized melanoma, own a smartphone, have a partner to help with skin checks, and regularly visit skin clinics in Australia. We analyzed responses from the first 100 participants who answered two questions about their motivations and expectations for joining the trial. Three independent coders categorized the responses, and we checked for new themes from other participants in the trial.

Results

Out of 100 participants, 98 responded to at least one question. We found three main themes in their answers:

  • Community Benefit: Many participants wanted to help advance medical research and support future melanoma patients.
  • Personal Benefit: Participants expected improvements in their health outcomes, such as earlier diagnosis and better access to care.
  • Trust in Healthcare Providers: A strong relationship with their healthcare providers motivated their participation.

Participants also expressed a desire to gain knowledge about their health and were interested in the benefits of teledermatology.

Conclusions

This study highlights the importance of understanding what drives patients to engage in clinical research. The findings show that altruism, self-empowerment, and the benefits of teledermatology are key motivators. These insights can improve the consent process, recruitment, and participant engagement in clinical trials.

Trial Registration

Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12621000176864.

Value of Clinical Trials

Clinical trials are essential for developing effective treatments. Our AI-driven platform, DocSym, consolidates clinical standards and research into an accessible resource for healthcare providers.

Streamlining Healthcare Operations

In today’s healthcare landscape, efficiency is vital. Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, enhancing patient care and expanding digital services.

Improving Patient Outcomes

By leveraging AI, clinics can optimize workflows and improve patient outcomes while reducing paperwork. Discover how we can assist at aidevmd.com.

AI Products for Business or Try Custom Development

AI Sales Bot

Welcome AI Sales Bot, your 24/7 teammate! Engaging customers in natural language across all channels and learning from your materials, it’s a step towards efficient, enriched customer interactions and sales

AI Document Assistant

Unlock insights and drive decisions with our AI Insights Suite. Indexing your documents and data, it provides smart, AI-driven decision support, enhancing your productivity and decision-making.

AI Customer Support

Upgrade your support with our AI Assistant, reducing response times and personalizing interactions by analyzing documents and past engagements. Boost your team and customer satisfaction

AI Scrum Bot

Enhance agile management with our AI Scrum Bot, it helps to organize retrospectives. It answers queries and boosts collaboration and efficiency in your scrum processes.